Article Details

Lonza invests in Singapore to support growth in mammalian biologics - BioPharma Reporter

Retrieved on: 2021-10-11 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

Lonza invests in Singapore to support growth in mammalian biologics - BioPharma Reporter. View article details on hiswai:

Excerpt

Its Singapore team now has the capability to perform extensive characterization of biopharmaceuticals using mass spectrometry. Lonza said the expansion will ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up